Kiadis Pharma NV (EURONEXT:KDS)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - KDS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - KDS

  • Market Cap€61.860m
  • SymbolEURONEXT:KDS
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINNL0011323407

Company Profile

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.Kiadis Pharma NV is a Netherlands based clinical stage biopharmaceutical company. It is focused on research, development and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders.

Latest KDS news

Currently there for this company. Visit our news hub for other news .